Stanford University
Showing 251-260 of 353 Results
-
Tawna L. Roberts, OD, PhD
Associate Professor of Ophthalmology (Pediatric) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsOur research efforts are funded by grants from the National Eye Institute, Department of Defense, and various foundations to study vision development in infants and young children as well as binocular vision disorders in adolescents and adults with concussions. Our focus is to identify underlying mechanisms that will inform clinical treatment approaches and ultimately leading to the prevention of strabismus, amblyopia, and binocular vision disorders.
-
Andrew Rong, MD
Associate Professor of Ophthalmology (Research/Clinical Trials)
BioDr. Andrew J. Rong is a board-certified, fellowship-trained oculofacial plastic, reconstructive, and orbital surgeon with Stanford Health Care. He is also an associate professor in the Department of Ophthalmology, Division of Oculoplastic, Reconstructive, and Orbital Surgery at Stanford University School of Medicine.
Dr. Rong has extensive expertise in cosmetic, functional, and reconstructive eyelid surgery. He specializes in upper and lower blepharoplasty, ptosis repair, revision eyelid surgery, brow lifting, and natural-looking periocular rejuvenation. He also treats eyelid tumors, eyelid malposition, thyroid eye disease, orbital tumors, and other complex conditions affecting the eyelids and eye socket. Dr. Rong performs advanced eyelid and periocular reconstruction following trauma, cancer treatment, and previous surgery. Whether performing cosmetic or reconstructive eyelid surgery, he provides individualized care designed to preserve eyelid function while achieving balanced, natural-looking results.
Dr. Rong graduated summa cum laude from the University of California, Los Angeles, with a degree in Microbiology, Immunology, and Molecular Genetics. He received his medical degree from the University of California, Davis, where he was elected to the Alpha Omega Alpha Honor Medical Society. He completed both his ophthalmology residency and oculoplastic surgery fellowship at Bascom Palmer Eye Institute. He subsequently joined the faculty at Bascom Palmer and served as Director of the Oculoplastic, Reconstructive, and Orbital Surgery Division, leading one of the country’s largest academic oculoplastic surgery services before returning to his native California and joining Stanford.
A major focus of Dr. Rong’s academic work is oculoplastic oncology, particularly sebaceous carcinoma of the ocular adnexa. His research seeks to improve how eyelid and periocular cancers are detected, characterized, and treated through molecular diagnostics, biomarker discovery, and translational laboratory models. His work has advanced the understanding of sebaceous carcinoma biology, including the identification of novel diagnostic markers and investigation of emerging therapeutic approaches. Dr. Rong has also developed and published innovative surgical techniques for complex eyelid, ocular surface, orbital, and periocular reconstruction, including reconstruction following lacrimal and periocular tumor resection.
Dr. Rong has authored numerous peer-reviewed publications, abstracts, and book chapters. He has lectured nationally and internationally on eyelid and periocular cancers, sebaceous carcinoma, ocular surface reconstruction, orbital surgery, cosmetic oculofacial surgery, and complex oculoplastic techniques. His research has been supported by grant and philanthropic funding and published in leading ophthalmology journals.
Dr. Rong is a member of the American Society of Ophthalmic Plastic and Reconstructive Surgery and has been recognized as a Castle Connolly Top Doctor. Outside of medicine, he enjoys spending time with his wife and two young daughters. -
Jennifer Rose-Nussbaumer
Alan Adler Global Ophthalmology Professor
BioDr. Jennifer Rose-Nussbaumer is a board-certified ophthalmologist and fellowship-trained cornea specialist at the Byers Eye Institute at Stanford University. Her clinical practice focuses on corneal transplantation, complex cataract surgery, and the treatment of infectious keratitis.
After completing her fellowship in Cornea and External Disease at the University of California, San Francisco (UCSF), Dr. Rose-Nussbaumer joined the faculty there and remained until 2021, when she transitioned to Stanford. What she loves most about medicine is caring for individual patients—building relationships, understanding each person's unique needs, and guiding them through their treatment with compassion and personalized attention.
In addition to her clinical work, Dr. Rose-Nussbaumer is an NIH-funded physician-scientist whose research centers on randomized clinical trials in ophthalmology. Her research is deeply rooted in her clinical practice: she is passionate about identifying the important, unanswered questions that arise while caring for patients, designing rigorous clinical trials to find the answers, and bringing that new knowledge back to the bedside to improve patient care.
She is the Principal Investigator on a UG1 grant supporting the **Descemet Endothelial Thickness Comparison Trial (DETECT)**, a randomized clinical trial comparing ultra-thin DSAEK (UT-DSAEK) to DMEK, and ripasudil to placebo, in patients with endothelial disease such as Fuchs Endothelial Dystrophy. She is also Principal Investigator on the **Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II)**, a randomized clinical trial conducted in collaboration with Aravind Eye Hospital in India and the University of São Paulo, evaluating the benefit of adjunctive topical steroids, corneal crosslinking, and rose bengal photodynamic therapy in the treatment of infectious corneal ulcers.
A native of Northern California, Dr. Rose-Nussbaumer enjoys spending time with her family and their Bernese Mountain Dog, Kenji, exploring the state's natural beauty through hiking and camping.
